Bank of Montreal
MYGN icon

Bank of Montreal’s Myriad Genetics MYGN Stock Holding History

Bank of Montreal’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,574
Closed -$77.4K – 3722
2025
Q2 		$77.4K Sell
14,574
-1,590
-10% -$9.39K ﹤0.01% 3048
2025
Q1 		$143K Buy
16,164
+3,166
+24% +$38K ﹤0.01% 2825
2024
Q4 		$178K Buy
12,998
+464
+4% +$8.56K ﹤0.01% 2800
2024
Q3 		$332K Sell
12,534
-136
-1% -$3.68K ﹤0.01% 2703
2024
Q2 		$313K Sell
12,670
-517
-4% -$11.3K ﹤0.01% 2706
2024
Q1 		$283K Sell
13,187
-84,631
-87% -$1.82M ﹤0.01% 2821
2023
Q4 		$2.01M Buy
97,818
+85,764
+711% +$1.48M ﹤0.01% 1684
2023
Q3 		$205K Sell
12,054
-183,238
-94% -$3.49M ﹤0.01% 3050
2023
Q2 		$4.63M Buy
195,292
+181,049
+1,271% +$3.95M ﹤0.01% 1374
2023
Q1 		$337K Buy
14,243
+2,349
+20% +$47.7K ﹤0.01% 2714
2022
Q4 		$200K Sell
11,894
-649
-5% -$12.1K ﹤0.01% 3161
2022
Q3 		$281 Sell
12,543
-37,431
-75% -$859K ﹤0.01% 2978
2022
Q2 		$1.07K Sell
49,974
-15,484
-24% -$322K ﹤0.01% 2258
2022
Q1 		$1.69M Buy
65,458
+39,052
+148% +$999K ﹤0.01% 2031
2021
Q4 		$737K Sell
26,406
-2,945
-10% -$85.3K ﹤0.01% 2133
2021
Q3 		$947K Sell
29,351
-2,613
-8% -$86.8K ﹤0.01% 2533
2021
Q2 		$980K Buy
31,964
+5,251
+20% +$152K ﹤0.01% 2496
2021
Q1 		$760K Buy
26,713
+2,294
+9% +$65.1K ﹤0.01% 2391
2020
Q4 		$622K Buy
24,419
+13,582
+125% +$219K ﹤0.01% 2586
2020
Q3 		$144K Buy
10,837
+259
+2% +$3.28K ﹤0.01% 2897
2020
Q2 		$121K Buy
10,578
+8,313
+367% +$118K ﹤0.01% 2999
2020
Q1 		$31K Sell
2,265
-113,440
-98% -$2.4M ﹤0.01% 3089
2019
Q4 		$3.15M Buy
115,705
+35,688
+45% +$982K ﹤0.01% 1624
2019
Q3 		$2.29M Buy
80,017
+16,061
+25% +$468K ﹤0.01% 1596
2019
Q2 		$1.78M Sell
63,956
-27,274
-30% -$770K ﹤0.01% 1760
2019
Q1 		$3.03M Sell
91,230
-4,339
-5% -$132K ﹤0.01% 1445
2018
Q4 		$2.78M Buy
95,569
+1,847
+2% +$66.4K ﹤0.01% 1359
2018
Q3 		$4.31M Buy
93,722
+21,176
+29% +$942K ﹤0.01% 1271
2018
Q2 		$2.71M Sell
72,546
-20,874
-22% -$705K ﹤0.01% 1484
2018
Q1 		$2.76M Buy
93,420
+3,157
+3% +$107K ﹤0.01% 1419
2017
Q4 		$3.1M Sell
90,263
-134,583
-60% -$4.54M ﹤0.01% 1367
2017
Q3 		$8.14M Sell
224,846
-23,239
-9% -$663K 0.01% 942
2017
Q2 		$6.41M Buy
248,085
+135,935
+121% +$2.89M 0.01% 1054
2017
Q1 		$2.15M Buy
112,150
+5,529
+5% +$98K ﹤0.01% 1491
2016
Q4 		$1.78M Buy
106,621
+163
+0.2% +$2.95K ﹤0.01% 1624
2016
Q3 		$2.19M Sell
106,458
-7,394
-6% -$188K ﹤0.01% 1448
2016
Q2 		$3.48M Buy
113,852
+5,382
+5% +$187K ﹤0.01% 1244
2016
Q1 		$4.06M Buy
108,470
+32,712
+43% +$1.23M ﹤0.01% 1116
2015
Q4 		$3.27M Buy
75,758
+17,841
+31% +$754K ﹤0.01% 1175
2015
Q3 		$2.17M Buy
57,917
+1,625
+3% +$57.7K ﹤0.01% 1268
2015
Q2 		$1.91M Sell
56,292
-310,306
-85% -$10.6M ﹤0.01% 1404
2015
Q1 		$13M Sell
366,598
-63,111
-15% -$2.26M 0.02% 695
2014
Q4 		$14.6M Sell
429,709
-372,827
-46% -$13.2M 0.02% 614
2014
Q3 		$31M Sell
802,536
-93,784
-10% -$3.5M 0.04% 379
2014
Q2 		$34.9M Buy
896,320
+62,650
+8% +$2.33M 0.04% 331
2014
Q1 		$28.5M Buy
833,670
+306,427
+58% +$9.49M 0.04% 337
2013
Q4 		$11.1M Buy
527,243
+436,365
+480% +$11M 0.02% 561
2013
Q3 		$2.13M Buy
90,878
+18,771
+26% +$533K ﹤0.01% 1139
2013
Q2 		$1.94M Buy
+72,107
New +$2.09M ﹤0.01% 1112

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's MYGN Position: Q3 2025 in Review

Bank of Montreal sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 14,574 shares — an estimated $77.4K sold.

Bank of Montreal first reported a position in MYGN in Q2 2013 and held it in 49 quarters. The position peaked at $34.9M in Q2 2014. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Bank of Montreal reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 14,574 Myriad Genetics shares in Q3 2025, an estimated $77.4K.
  • Bank of Montreal first reported a position in Myriad Genetics in Q2 2013 and held it in 49 quarters.
  • Bank of Montreal's Myriad Genetics position peaked at $34.9M in Q2 2014.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.